Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance / [electronic resource] :
J. Rick Turner, Todd A. Durham.
- Hoboken, N.J. : John Wiley & Sons, c2009.
- xxviii, 470 p. : ill.
Includes bibliographical references (p. 397-455) and index.
The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety.
Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.
0470229640 (cloth) 9780470229644 (cloth)
DNLM
Cardiovascular toxicology. Drugs--Safety measures. Drugs--Side effects--Testing. Heart--Effect of drugs on.